The Big Idea of the Week delves deeper into a specific COVID-related topic. Each week, Big Idea tackles a specific area of COVID-19 and provides important information, guidelines, and messages for the public.
COVID-19 and Gender / Gender-Based Violence
Women have shown better COVID-19 outcomes than men - in part thanks to an additional X chromosome and sex hormones like oestrogen, which provoke better immune responses to the virus that causes COVID-19. But any such advantage is reversed when it comes to the social and economic effects of the pandemic; here the brunt falls heaviest on women.
This document provides guidance on how to safely deliver gender-based violence (GBV) services during the COVID-19 pandemic.
This website is the product of an international committee that brings together academics who conduct real time gender analysis to identify and document the gendered dynamics of COVID-19 and gaps in preparedness and response.
The COVID-19 pandemic has unmasked underlying inequities. Measures such as lockdown and physical distancing have confined many people to isolated, unsafe places that may increase risk of gender-based violence (GBV).
The COVID-19 pandemic is largely concentrated in cities and urban areas, with around 2,600 cities globally reporting at least one case of the disease. While the epicentre of the global health crisis is still Europe and North America, its impact on developing countries may be more devastating, especially for the poorest. The 1 billion+ people living in slums and slum-like settings in developing countries, where population density is high, are those most at-risk and least prepared.
Integrating gender into the COVID-19 risk communication and community engagement (RCCE) response demands consideration of how gender norms and roles, as well as inequitable power dynamics and decision-making, influence people’s experiences and needs at all stages.
This document presents an initial summary of potential gender-based violence (GBV) risk mitigation actions, based on established good practice, that are starting points to address GBV risks in this unprecedented situation.
This resource provides practitioners with key resources to support the integration of GBV risk mitigation into COVID-19 response. It will be frequently updated as the crisis unfolds.